ZINECARD

Product Overview

About ZINECARD

ZINECARD is a medicinal product containing the active ingredient DEXRAZOXANE, primarily used in the medical field for its cardioprotective properties. It is designed to reduce the risk of cardiotoxicity in patients undergoing certain types of chemotherapy. By mitigating the harmful effects of anthracyclines on the heart, ZINECARD plays a crucial role in the management of cancer treatment side effects.

Key Benefits & Uses

• Reduces the risk of cardiotoxicity associated with anthracycline chemotherapy
• Protects the heart from damage caused by certain cancer treatments
• Supports the continuation of essential chemotherapy regimens by minimizing cardiac side effects

Active Ingredient & Action

DEXRAZOXANE, the active ingredient in ZINECARD, works by binding to metal ions, which are involved in the production of free radicals that can damage cardiac cells. By chelating these metal ions, DEXRAZOXANE reduces the formation of free radicals, thereby protecting the heart from the cardiotoxic effects of anthracyclines. This mechanism of action allows for the safe administration of chemotherapy while safeguarding cardiac function.

Important Notes

It is essential to follow the prescribed dosage and administration guidelines for ZINECARD. Patients should inform their healthcare provider about any pre-existing medical conditions, especially those related to the heart, and about all medications they are currently taking. Regular monitoring of cardiac function is recommended during treatment with ZINECARD. As with any medication, it is crucial to discuss the potential benefits and risks with a healthcare professional before starting treatment.